Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

TAU researcher connects computer communications and psychosis

As Internet access becomes increasingly widespread, so do related psychopathologies such as Internet addiction and delusions related to the technology and to virtual relationships. Computer communications such as Facebook and chat groups are an important part of this story, says Dr. Uri Nitzan of Tel Aviv University's Sackler Faculty of Medicine and the Shalvata Mental Health Care Center in a new paper published in the Israel Journal of Psychiatry and Related Sciences.

21 Nov 2012

Neurologist care lowers risk for PD-related hospitalizations

Regular care by a neurologist lowers the risk for hospitalization for Parkinson's disease-related complications, US research shows.

20 Nov 2012

Young-onset Parkinson's most common in White men

Young-onset Parkinson's disease is most common among White individuals and men in America, research shows.

20 Nov 2012

White matter alterations evident before psychosis development

Results from a UK study show that white matter integrity is reduced in patients at ultra-high risk for psychosis, although to a lesser extent than in first-episode psychosis patients.

15 Nov 2012

Cannabis withdrawal clinically significant in schizophrenia

Cannabis withdrawal symptoms are clinically significant in schizophrenia patients as they are often associated with behavioral change, say researchers.

15 Nov 2012

AKT1 genotype influences risk of psychotic disorders in cannabis users

The ability of cannabis to produce psychosis has long been an important public health concern. This concern is growing in importance as there is emerging data that cannabis exposure during adolescence may increase the risk of developing schizophrenia, a serious psychotic disorder. Further, with the advent of medical marijuana, a new group of people with uncertain psychosis risk may be exposed to cannabis.

15 Nov 2012

White matter alterations evident before psychosis development

Results from a UK study show that white matter integrity is reduced in patients at ultra-high risk for psychosis, although to a lesser extent than in first-episode psychosis patients.

13 Nov 2012

Pay-for-performance schemes may help save lives of NHS patients

New research into controversial pay-for-performance schemes has suggested they may help to save the lives of NHS patients.

From The University of Manchester 8 Nov 2012

Cannabis use causes temporary cognitive breakdown in non-psychotic individuals: Study

Researchers at the University of Bergen in Norway have found new support for their theory that cannabis use causes a temporary cognitive breakdown in non-psychotic individuals, leading to long-term psychosis.

3 Nov 2012

Social disadvantage may increase risk for psychosis

Results from a UK study suggest that social disadvantage is associated with an increased risk for developing psychosis.

1 Nov 2012

FDA accepts Sunovion’s two LATUDA sNDAs for review

Sunovion Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review two supplemental New Drug Applications (sNDAs) for the use of LATUDA as 1) monotherapy and 2) adjunctive therapy to lithium or valproate, both to treat adult patients with depressive episodes associated with bipolar I disorder (bipolar depression).

31 Oct 2012

Homocysteine not linked to cognition in FEP

Patients experiencing a first episode of psychosis have significantly higher homocysteine levels than mentally healthy individuals, researchers report.

26 Oct 2012

Social disadvantage may increase risk for psychosis

Results from a UK study suggest that social disadvantage is associated with an increased risk for developing psychosis.

25 Oct 2012

Ethnic density linked to psychosis risk

Reduced own-group ethnic density within a given geographic area is associated with an increased risk for psychotic experiences, results from a UK study show.

24 Oct 2012

Antipsychotic drug quandary for Alzheimer’s patients

Stopping treatment with risperidone to limit side effects risks the return of psychosis or agitation in patients with Alzheimer’s disease who have been taking the drug to suppress such symptoms, research shows.

23 Oct 2012

Pfizer announces intention to acquire NextWave

Pfizer Inc. today announced its intention to acquire NextWave Pharmaceuticals, a privately held, specialty pharmaceutical company focused on the development and commercialization of unique products for the treatment of attention deficit/hyperactivity disorder (ADHD) and related central nervous system (CNS) disorders.

23 Oct 2012